✦ LIBER ✦

Cost-effectiveness of cognitive–behavioral therapy for depression: current evidence and future research priorities

✍ Scribed by Byford, Sarah; Bower, Peter

Book ID: 120511041
Publisher: Expert Reviews
Year: 2002
Tongue: English
Weight: 134 KB
Volume: 2
Category: Article
ISSN: 1473-7167
DOI: 10.1586/14737167.2.5.457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of particle therapy:

Cost-effectiveness of particle therapy: Current evidence and future needs

✍ Madelon Pijls-Johannesma; Pascal Pommier; Yolande Lievens 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Cost-Effectiveness Analysis for Antidepr

Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand

✍ Benjamas Prukkanone; Theo Vos; Melanie Bertram; Stephen Lim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 984 KB

931 POSTER Cost-effectiveness of particl

931 POSTER Cost-effectiveness of particle therapy: current evidence and future needs

✍ M. Pijls-Johannesma; D. De Ruysscher; P. Lambin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Cost-effectiveness of cognitive–behaviou

Cost-effectiveness of cognitive–behavioural therapy and drug interventions for major depression

✍ Theo Vos; Justine Corry; Michelle M. Haby; Rob Carter; Gavin Andrews 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 110 KB

Cognitive behaviour therapy (CBT) for th

Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: Current evidence and directions for future research

✍ LEANNE HIDES; SHARON SAMET; DAN I. LUBMAN 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 155 KB

Cost-effectiveness and cost-utility of c

Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (prozac) in treating depression: a randomized clinical trial

✍ Florin A. Sava; Brian T. Yates; Viorel Lupu; Aurora Szentagotai; Daniel David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Abstract Cost‐effectiveness and cost‐utility of cognitive therapy (CT), rational emotive behavioral therapy (REBT), and fluoxetine (Prozac) for major depressive disorder (MDD) were compared in a randomized clinical trial with a Romanian sample of 170 clients. Each intervention was offered for 14